Exxon Mobil (XOM) reported $84.34 billion in revenue for the quarter ended December 2023, representing a year-over-year decline of 11.6%. EPS of $2.48 for the same period compares to $3.40 a year ago.
The reported revenue represents a surprise of -8.14% over the Zacks Consensus Estimate of $91.81 billion. With the consensus EPS estimate being $2.21, the EPS surprise was +12.22%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Exxon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Oil-equivalent production per day: 3,824 KBOE/D versus the six-analyst average estimate of 3,769.47 KBOE/D.
- Natural gas production available for sale per day - Worldwide: 7,645 Mcf/D compared to the 7,815.52 Mcf/D average estimate based on five analysts.
- Net production of crude oil, natural gas liquids, bitumen and synthetic oil per day - Worldwide: 2550 thousands of barrels of oil compared to the 2475.58 thousands of barrels of oil average estimate based on five analysts.
- Natural gas production available for sale per day - Asia: 3,486 Mcf/D compared to the 3,585.2 Mcf/D average estimate based on four analysts.
- Chemical Products sales- United States: $1.74 billion versus the three-analyst average estimate of $1.79 billion.
- Chemical Products sales- Non-U.S. $3.03 billion versus the three-analyst average estimate of $3.40 billion.
- Specialty Products sales- Worldwide: $1.84 billion compared to the $1.87 billion average estimate based on three analysts.
- Specialty Products sales- United States: $473 million versus the three-analyst average estimate of $486.69 million.
- Specialty Products sales- Non-U.S. $1.37 billion versus the three-analyst average estimate of $1.38 billion.
- Revenues- Sales and other operating revenue: $81.69 billion versus the five-analyst average estimate of $92.81 billion. The reported number represents a year-over-year change of -12.3%.
- Revenues- Income from equity affiliates: $1.17 billion compared to the $1.31 billion average estimate based on three analysts. The reported number represents a change of +92.6% year over year.
- Revenues- Other income: $1.49 billion versus the three-analyst average estimate of $1.07 billion. The reported number represents a year-over-year change of -10.2%.
Shares of Exxon have returned +0.1% over the past month versus the Zacks S&P 500 composite's +2.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>Exxon Mobil Corporation (XOM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
